VECT-HORUS, a biotechnology company that designs and develops vectors facilitating targeting of therapeutic molecules and imaging agents, announces completion of a new fund-raising round for 3.5 million euros, following a previous round of 2.5 million euros in 2017. In this new round participated historic shareholders and also new entrants including CAAP Création, a subsidiary of Crédit Agricole Alpes Provence, Financière Tuileries Co-Invest and SCR Provençale et Corse, subsidiary of Banque Populaire Méditerranée (BPM). In total, VECT-HORUS has raised more than 22 M€ since its inception, including 8 M€ in public research grants and research tax credits.